JASMINE SOLOMON: Open Payments
NPI 1083259741 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,470 in 66 payments from 14 companies in 2025. Trend: 2023 $1,598 · 2024 $1,576 · 2025 $1,470
Food & beverage: $1,470
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $365 |
| ABBVIE INC. | 13 | $226 |
| Otsuka America Pharmaceutical, Inc. | 8 | $184 |
| Teva Pharmaceuticals USA, Inc. | 9 | $141 |
| Neurocrine BioSciences, Inc. | 5 | $129 |
| Vanda Pharmaceuticals Inc. | 4 | $102 |
| Lundbeck LLC | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Alkermes, Inc. | 1 | $33 |
Products named: CAPLYTA, REXULTI, VRAYLAR, AUSTEDO XR, INGREZZA, FANAPT, TRINTELLIX, Auvelity.
Industry payments across NY — which companies pay providers there.
